Literature DB >> 15547704

The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines.

S Schweyer1, A Soruri, A Heintze, H J Radzun, A Fayyazi.   

Abstract

Testicular germ cell tumours (TGCT) are the most common solid tumour among young males. Whereas in 1970s, only 5% of patients with a metastatic testicular tumours survived their disease, these days 80% of patients treated by modern cisdiamminedichloroplatinum (cisplatin, CDDP)-based chemotherapy are cured. Although data are accumulating on the effect of the mitogen-activated protein kinase (MAPK) family on the CDDP-induced apoptosis in tumour cells, the mechanisms by which CDDP initiates apoptosis in TGCT are not completely understood. Applying Western blot and phosphorylated kinase-specific ELISA analyses, flow cytometry, blocking experiments, and morphological methods we sought here to define the MAPK pathway(s) involved in the CDDP-induced apoptosis in the human TGCT cell line NCCIT. Our experiments showed that within hours of CDDP application only the extracellular signal-regulated kinase (ERK) was dually phosphorylated and caspase-3 became active. Functional assays using chemical inhibitors demonstrated that the phosphorylation of ERK was mediated by reactive oxygen species in an Raf-1-independent manner and required the activation of caspase-3. Thus, our data suggest that CDDP mediates its apoptosis-inducing effect on the human malignant testicular germ cells, at least partially, through activation of the MEK-ERK signaling pathway in a ROS-dependent, Raf-1-independent manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547704     DOI: 10.3892/ijo.25.6.1671

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  Casiopeína IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cells.

Authors:  Remy Kachadourian; Heather M Brechbuhl; Lena Ruiz-Azuara; Isabel Gracia-Mora; Brian J Day
Journal:  Toxicology       Date:  2009-12-23       Impact factor: 4.221

2.  Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.

Authors:  Caryl J Giuliano; Sarah J Freemantle; Michael J Spinella
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

3.  The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.

Authors:  Yongke Lu; Arthur Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-07-06       Impact factor: 7.376

4.  Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.

Authors:  Jinlong Shi; Baolan Sun; Wei Shi; Hao Zuo; Daming Cui; Lanchun Ni; Jian Chen
Journal:  Tumour Biol       Date:  2014-10-05

5.  Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion.

Authors:  Remy Kachadourian; Heather M Leitner; Brian J Day
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

6.  Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.

Authors:  M K L Fung; H-W Cheung; M-T Ling; A L M Cheung; Y-C Wong; X Wang
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

7.  Effects of Novel Dinuclear Cisplatinum(II) Complexes on the Electrical Properties of Human Molt-4 Leukemia Cells.

Authors:  Izabela Dobrzyńska; Elżbieta Skrzydlewska; Zbigniew A Figaszewski
Journal:  Cell Biochem Biophys       Date:  2015-04       Impact factor: 2.194

8.  USP2a alters chemotherapeutic response by modulating redox.

Authors:  B Benassi; M Marani; M Loda; G Blandino
Journal:  Cell Death Dis       Date:  2013-09-26       Impact factor: 8.469

9.  Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.

Authors:  Miriana Hijaz; Soumen Das; Ismail Mert; Ankur Gupta; Zaid Al-Wahab; Calvin Tebbe; Sajad Dar; Jasdeep Chhina; Shailendra Giri; Adnan Munkarah; Sudipta Seal; Ramandeep Rattan
Journal:  BMC Cancer       Date:  2016-03-15       Impact factor: 4.430

10.  Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.

Authors:  Bong Hee Park; Joung Eun Lim; Hwang Gyun Jeon; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon; Byong Chang Jeong
Journal:  Oncotarget       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.